Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAK-901 |
Trade Name | |
Synonyms | |
Drug Descriptions |
TAK-901 is a selective inhibitor of Aurora B kinase, FLT3, and FGFR2, and has demonstrated anti-tumor activity in several cancer models (PMID: 23358665, PMID: 28179288). |
DrugClasses | Aurkb Inhibitors 21 FGFR2 Inhibitor 23 FLT3 Inhibitor 69 |
CAS Registry Number | 934541-31-8 |
NCIT ID | C82674 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Navitoclax + TAK-901 | Navitoclax TAK-901 | 0 | 0 |
TAK-901 | TAK-901 | 0 | 0 |